Healthcare IBD - Summary & Resources
####WSO resources
[Healthcare Overview](https://www.wallstreetoasis.com/forums/healthcare…)
[Biotech Finance: From IB to VC / HF to Funded Startup (Part 1)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Biotech Finance: Valuation Methodologies And Modeling Considerations (Part 2)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Q&A: BB IBD Healthcare Analyst](https://www.wallstreetoasis.com/forums/q&a-bb-ibd…)
[Questions About Healthcare M&A](https://www.wallstreetoasis.com/forums/questions-…)
[Guide to Evaluate a Biotech Company](https://www.wallstreetoasis.com/forums/guide-to-e…)
####External resources (news and reports)
[FierceBiotech](https://www.fiercebiotech.com/)
[FiercePharma](https://www.fiercepharma.com/)
[Biospace](https://www.biospace.com/news/)
[WSJ Health](https://www.wsj.com/news/business/health-industry)
[Medscape](https://www.medscape.com/)
[Bain's Global Healthcare Private Equity and Corporate M&A reports][]
[Paul Keckley's weekly report](https://www.paulkeckley.com/the-keckley-report)
[Axios Vitals](https://www.axios.com/newsletters/axios-vitals)
Medical device industry:
[Fierce MedTech](https://www.fiercebiotech.com/medtech)
[MassDevice](https://www.massdevice.com/)
[Medical Device Manufacturers Association](https://www.medicaldevices.org/news/)
####Books
**- "The Pharmagellan Guide to Biotech Forecasting and Valuation"**
**- "Biotechnology Valuation", Karl Kleegan**: Chapter 3 is about the drug development process. You can also check Chapter 4 to learn how to build a disease model. However, read this book only if you already know valuation (DCF, comps), because the author uses quick-n-dirty or overly complex techniques that you shouldn't follow as an investment banker (he was an ER guy).
####Graphic on the industry
!PHARMA(https://www.wallstreetoasis.com/files/styles/w800…)
####Bonus videos
*How To Analyze a Clinical Trial:* not directly related to IB, but still interesting in order to understand how clinical trials work and the effect of their results on share price
[Part 1](
[Part 2](https://www.youtube.com/watch?v=A-hYVtCA06c)
[Part 3]()
[Part 4](https://www.youtube.com/watch?v=_aO5BhyEgXo)
Anything I should add?
**Thanks to TheFlyingKiwi(https://www.wallstreetoasis.com/user/423544)!**
[Bain's Global Healthcare Private Equity and Corporate M&A reports]: https://www.bain.com/insights/topics/global-healt…
[Medscape]: https://www.medscape.com/
Solid thread. +1 and following.
I'd add https://www.paulkeckley.com/the-keckley-report</a">Paul Keckley's weekly report to the ex resources. He does great political analysis and provides insight from government and survey data.
https://www.medscape.com/</a">Medscape
https://www.fiercebiotech.com/medtech</a">Fierce MedTech
https://www.massdevice.com/</a">Mass Device
WSJ Health
https://www.medicaldevices.org/news/</a">Med Dev Manufacturers Assoc (I just follow the Twitter account)
WSO:
https://www.wallstreetoasis.com/forums/biotech-finance-part-2-valuation…</a">Biotech Finance Part 2: Valuation Methodologies And Modeling Considerations
https://www.wallstreetoasis.com/forums/guide-to-evaluate-a-biotech-comp…</a">Guide To Evaluate A Biotech Company
Nice graphic on the industry.
Can't think of anymore off the top of my head. Looking forward to what others say as well.
I'm adding your links, thanks!
Cheers! Would be interested if other users follow any individual Twitter accounts that posts good insights/knowledge. Always hard to find those.
bump
bump
bump
bump
Bump
Bump
Bump
Bump
Bump
https://www.mobihealthnews.com/
I work in HCIT corporate right now and read a lot from this website as well as CB Insights Digital Health (very solid). Pretty sure HW or HL has a public report about HCIT companies in 2020 (fairly in depth, similar to CB Insights).
Associate exit opps?
bump
Bump
wondering if anyone has any good healthcare business books?
Bump
B
B
Maxime quas velit recusandae qui dignissimos facere perspiciatis non. Molestias odio sint aut maxime recusandae et. Labore libero optio error id aperiam et rerum. Laboriosam voluptatem error voluptatum asperiores eaque nostrum exercitationem cupiditate. Natus qui ipsam dolores omnis dolorem recusandae placeat ipsa.
Ut exercitationem sunt nobis qui. Itaque quisquam dignissimos earum animi nihil rerum reiciendis. Nulla corporis pariatur quis quisquam sed placeat libero voluptate. Omnis iure similique qui neque temporibus. Quia ut id quia voluptatem consequatur.
Consequatur consequatur laboriosam reiciendis et debitis in. Mollitia illum qui dolore cupiditate optio voluptatum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Velit molestiae aut ab accusantium ut sed ullam. Veritatis qui aut laboriosam sed. Vel deleniti incidunt placeat. Dolores architecto itaque totam praesentium hic est. Consectetur non quis ad nulla ratione odit.
In placeat aut ut doloribus tempore. Sit rem et nobis eaque consequatur quod ducimus aut. Et harum officia harum deleniti. In sit beatae omnis excepturi.
Dolore reprehenderit corporis qui ab libero quia distinctio reprehenderit. Sequi temporibus porro deserunt sequi enim. Sed ut magni sed delectus nam qui qui ex. Non vero aut voluptate voluptatibus et. Eos vel error delectus animi distinctio voluptates praesentium. Ducimus et voluptatum suscipit optio.
Vitae culpa qui tenetur nostrum voluptas. Voluptas delectus rerum quia sapiente. Voluptatem distinctio recusandae explicabo sunt maiores blanditiis sit.